The No Surprises Act's Unintended Consequence: A Multi-Billion Dollar Headache for Healthcare

Remember the No Surprises Act? It felt like such a relief when Congress passed it back in December 2020. The whole idea was to shield folks like you and me from those gut-wrenching, unexpected medical bills after getting care from an out-of-network provider. It really aimed to level the playing field, making sure insurers and providers hashed out their payment disagreements either on their own or through a brand-new, independent arbitration process. It kicked off in 2022, and for a moment there, we all thought, 'Finally, some peace of mind.'

But, oh, how quickly things can go awry, especially in the intricate world of healthcare policy. When the law was first conceived, the Congressional Budget Office, bless their hearts, projected a modest outcome: a slight dip in private health plan premiums and maybe, just maybe, about 17,000 to 22,000 arbitration claims annually. A manageable number, right? Well, fast forward to today, July 2026, and the reality is nothing short of staggering. We're talking 6.3 million cases filed since 2022, with a mind-boggling 1.4 million of those piling up in just the first five months of this year alone. It's a deluge, a veritable tsunami of disputes.

And the financial impact? Frankly, it's just as alarming. Total payouts for these surprise billing squabbles hit nearly $15 billion in 2025. Let that sink in for a moment. That's more than triple the $4.1 billion paid out in 2024, and a truly astronomical leap from the $393 million seen in 2023. It’s a runaway train, and the numbers just keep climbing. One study even suggested that this Independent Dispute Resolution (IDR) process alone generated at least $5 billion in wasteful spending between 2022 and 2024, encompassing both administrative fees and those hefty arbitration awards.

So, what’s going on? It seems the system, intended to be a neutral arbiter, is heavily tilted. A 2024 CMS report revealed that arbitrators are siding with higher payment amounts in over 80% of these disputes. What's more, these awarded payments often exceed an insurer's median in-network rate. Think about that: a process meant to curb costs is frequently leading to higher payments than what’s typically negotiated. Insurers’ proposed amounts are accepted about 20% of the time, or even less. As CMS itself has candidly put it, "the system is being gamed to get higher prices."

You can imagine the frustration and even shock from those who understand the system. Jack Hoadley, a research professor emeritus at Georgetown University, openly expressed his disbelief at the rapid escalation of payouts. Lawson Mansell, a senior health policy analyst at the Niskanen Center, observed that there’s "no real end in sight" to this swelling tide of cases. And Chris Bond, speaking for AHIP, didn’t mince words, calling it "outrageous provider-driven abuse" that’s directly leading to "billions in wasteful spending and raising healthcare costs."

Indeed, the sentiment among many is that this arbitration system has become a bit of a "gold rush." The Washington Reporter editors, for example, have bluntly labeled it a "costly farce." And who are the biggest beneficiaries, you might ask? Well, physician groups, particularly those in specialties like radiology, anesthesiology, and emergency room care, along with private equity-backed physician groups, have been identified as major winners in this IDR process. An HHS report in 2026 confirmed that, contrary to its initial goals, the NSA is actually increasing costs for health plans, payers, and, yes, us, the patients. A whopping 85% of 2023 disputes involved private employer-sponsored health plans, meaning businesses and their employees are bearing the brunt.

So, where does this leave us? A coalition of over 60 diverse groups – including employers, insurers, patient advocacy organizations, and labor groups – has had enough. In February of this year, they sent a strong letter to the U.S. Departments of Treasury, Labor, and HHS, urgently calling for stricter oversight of the IDR system. They want to curb its manipulation and, by extension, rein in those escalating healthcare costs that affect us all. The conversation is ongoing; just this July 17th, CMS released new guidance related to the Act, and the American Medical Association submitted comments on a proposed rule, showing that the complexities continue to unfold.

It's a stark irony, isn't it? A law designed with the best of intentions – to protect us from financial surprises in healthcare – has, through its implementation, created a whole new set of economic headaches. We're witnessing a significant policy initiative veer off course, leading to inflated costs and a system that feels increasingly exploited. The question now is, what will it take to truly get it back on track?